✦ LIBER ✦
FP33-WE-01 TYSABRI® observational program: a long-term evaluation of safety and impact on disease activity and progression of natalizumab in relapsing-remitting MS
✍ Scribed by M. Trojano; H. Butzkueven; D. Goodin; L. Kappos; H. Wiendl; D. Desgrandchamps
- Book ID
- 119467787
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 47 KB
- Volume
- 285
- Category
- Article
- ISSN
- 0022-510X
No coin nor oath required. For personal study only.